blood cancer

Celgene plans filing for Revlimid/rituximab in lymphoma

https://pharmaphorum.com/news/celgene-plans-filing-for-revlimid-rituximab-in-lymphoma/

AbbVie raises hopes for blood cancer patients

https://pharmaphorum.com/news/venetoclax-abbvie-raises-hopes-blood-cancer-patients/

Amgen’s blood cancer drug gets full EU licence

https://pharmaphorum.com/news/amgens-blood-cancer-drug-blincyto-licence/

ASCO 2018 – Friday 1st and Saturday 2nd June: Bluebird Bio’s CAR-T shines, plus blood tests for lung cancer

https://pharmaphorum.com/views-analysis-oncology/asco-round-up-bluebird-bios-car-t-plus-lynch-syndrome-screening/

Pfizer will have to cut price of AML drug Mylotarg after NICE ruling

https://pharmaphorum.com/news/pfizer-cut-price-mylotarg/

Novartis matches Gilead on price in new CAR-T use

https://pharmaphorum.com/news/novartis-matches-gilead-kymriah/

AstraZeneca files cancer drugs in US and EU

https://pharmaphorum.com/news/astrazeneca-files-cancer-drugs-us-eu/

Bluebird bio details plans to file three blockbusters

https://pharmaphorum.com/news/bluebird-bio-aims/

Natural killer cells ‘a hundred times cheaper’ than CAR-T

https://pharmaphorum.com/news/natural-killer-cancer-therapy-a-hundred-times-cheaper-than-car-t/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search